Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02759263 · ClinicalTrials.gov registry record · NA
Improving Neurodevelopment in Adolescents With Congenital Heart Disease
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02759263 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 60 participants.
The verdict
NCT02759263, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Executive dysfunction can profoundly impact all dimensions of a child's development. Impairments in executive function are a central component of the neurodevelopmental phenotype associated with CHD, and manifest as behavioral dysregulation and problems with attention, working memory, and organization/planning abilities. Identifying effective treatment strategies is vital for providing optimal care for these patients. The Cogmed executive function intervention, an evidence-based computerized neurocognitive program, improves outcomes in several pediatric populations. The investigators propose to conduct a pilot study to evaluate its efficacy in reducing morbidities in patients with CHD. This is a single center, single blinded 2-arm randomized controlled trial to test the immediate post-treatment and 3-month follow-up efficacy of Cogmed intervention versus standard of care in adolescents with CHD.
Interventions
- BEHAVIORAL Cogmed Working Memory Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02759263
The ClinicalTrials.gov registry entry for NCT02759263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cogmed Working Memory Training is the first listed.
NCT02759263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02759263 about?
NCT02759263 is a clinical study titled "Improving Neurodevelopment in Adolescents With Congenital Heart Disease". Executive dysfunction can profoundly impact all dimensions of a child's development. Impairments in executive function are a central component of the neurodevelopmental phenotype associated with CHD, and manifest as behavioral dysregulation and problems with attention, working memory, and organizati...
What is the current status of trial NCT02759263?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2016-06. Estimated completion is 2018-10.
What interventions are being tested in trial NCT02759263?
The interventions under investigation include: Cogmed Working Memory Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02759263?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.